You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT JAMA
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 261 No. 5, February 3, 1989 TABLE OF CONTENTS
  JAMA
  •  Online Features
  Grand Rounds at the National Institutes of Health
 This Article
 •References
 •Full text PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Contact me when this article is cited
 Related Content
 •Similar articles in JAMA
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Innovations in Monoclonal Antibody Tumor Targeting

Diagnostic and Therapeutic Implications

Jeffrey Schlom, PhD

JAMA. 1989;261(5):744-746.

Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

SELECTED CASE

A 33-YEAR-OLD woman presented with a history of infertility following a normal pregnancy three years previously. A hysterosalpingogram showed a fallopian tube blockage. She underwent an exploratory laparoscopy with findings that suggested chronic pelvic inflammatory disease. During a laparotomy for tubuloplasty she was found to have a ruptured adenocarcinoma of the appendix, with tumor coating the liver, diaphragm, and peritoneum. The peritoneal cavity was washed out. She remained asymptomatic, with no progression of disease seen during laparoscopy one year later. Three years later, during a physical examination, she was found to have a large, pelvic recurrence and underwent abdominal hysterectomy, bilateral salpingo-oophorectomy, omentectomy, and debulking of gross tumor, with residual tumor left behind. Radiographic evaluation, including a computed tomographic scan of the abdomen, an intravenous pyelogram, and a barium enema examination, showed no evidence of disease. She was then referred to the Surgery Branch of the National Cancer . . . [Full Text PDF of this Article]


Author Affiliations

From the Laboratory of Tumor Immunology and Biology, National Cancer Institute, National Institutes of Health, Bethesda, Md.


Footnotes

Reprint requests to the Laboratory of Tumor Immunology and Biology, National Cancer Institute, National Institutes of Health, Bldg 10, Room 8B07, Bethesda, MD 20892 (Dr Schlom).



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1989 American Medical Association. All Rights Reserved.